These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10809340)

  • 1. Contrast medium-induced nephrotoxicity: pathophysiology and prevention.
    Gerlach AT; Pickworth KK
    Pharmacotherapy; 2000 May; 20(5):540-8. PubMed ID: 10809340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency.
    Abizaid AS; Clark CE; Mintz GS; Dosa S; Popma JJ; Pichard AD; Satler LF; Harvey M; Kent KM; Leon MB
    Am J Cardiol; 1999 Jan; 83(2):260-3, A5. PubMed ID: 10073832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osmolality not predictive of mannitol-induced acute renal insufficiency.
    Gondim Fde A; Aiyagari V; Shackleford A; Diringer MN
    J Neurosurg; 2005 Sep; 103(3):444-7. PubMed ID: 16235675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).
    Morcos SK; Thomsen HS; Webb JA
    Eur Radiol; 1999; 9(8):1602-13. PubMed ID: 10525875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery.
    Sirivella S; Gielchinsky I; Parsonnet V
    Ann Thorac Surg; 2000 Feb; 69(2):501-6. PubMed ID: 10735688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
    Stevens MA; McCullough PA; Tobin KJ; Speck JP; Westveer DC; Guido-Allen DA; Timmis GC; O'Neill WW
    J Am Coll Cardiol; 1999 Feb; 33(2):403-11. PubMed ID: 9973020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low risk of contrast-medium-induced nephropathy with modern angiographic technique.
    Sterner G; Nyman U; Valdes T
    J Intern Med; 2001 Nov; 250(5):429-34. PubMed ID: 11887978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretics in acute kidney injury.
    Karajala V; Mansour W; Kellum JA
    Minerva Anestesiol; 2009 May; 75(5):251-7. PubMed ID: 18636060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of serum creatinine trajectory in acute contrast nephropathy.
    Guitterez NV; Diaz A; Timmis GC; O'Neill WW; Stevens MA; Sandberg KR; McCullough PA
    J Interv Cardiol; 2002 Oct; 15(5):349-54. PubMed ID: 12440177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
    Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
    Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast nephropathy, pathophysiology and prevention.
    Oudemans-van Straaten HM
    Int J Artif Organs; 2004 Dec; 27(12):1054-65. PubMed ID: 15645616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based therapy of acute renal failure.
    Lameire N; Vanholder R; Van Biesen W; De Vriese A; Dhondt A; Veys N; Hoeben H; Colardyn F
    Acta Clin Belg; 1999 Oct; 54(5):263-73. PubMed ID: 10555384
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proof of principle: hydration by low-osmolar mannitol-glucose solution alleviates undesirable renal effects of an iso-osmolar contrast medium in rats.
    Seeliger E; Ladwig M; Sargsyan L; Cantow K; Persson PB; Flemming B
    Invest Radiol; 2012 Apr; 47(4):240-6. PubMed ID: 22353855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
    Qian G; Fu Z; Guo J; Cao F; Chen Y
    JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
    Dussol B; Morange S; Loundoun A; Auquier P; Berland Y
    Nephrol Dial Transplant; 2006 Aug; 21(8):2120-6. PubMed ID: 16611682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of acute renal failure in patients with rhabdomyolysis.
    Homsi E; Barreiro MF; Orlando JM; Higa EM
    Ren Fail; 1997 Mar; 19(2):283-8. PubMed ID: 9101605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of contrast media nephrotoxicity--the story so far.
    Morcos SK
    Clin Radiol; 2004 May; 59(5):381-9. PubMed ID: 15081843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.
    Sam AD; Morasch MD; Collins J; Song G; Chen R; Pereles FS
    J Vasc Surg; 2003 Aug; 38(2):313-8. PubMed ID: 12891113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-induced nephropathy: review of incidence and pathophysiology.
    Quader MA; Sawmiller C; Sumpio BA
    Ann Vasc Surg; 1998 Nov; 12(6):612-20. PubMed ID: 9841696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.